U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Laboratory Tests | Ranitidine
  1. Drug Safety and Availability

Laboratory Tests | Ranitidine

Laboratory analysis of ranitidine and nizatidine products

FDA continues to investigate the presence of the N-Nitrosodimethylamine (NDMA) impurity in ranitidine and is now aware of NDMA in nizatidine, which is chemically similar to ranitidine. Both medicines are H2 blockers which decrease the amount of acid in the stomach. FDA has identified NDMA in ranitidine and nizatidine active pharmaceutical ingredient (API) and finished drugs.  

FDA is posting its laboratory results in the table below showing NDMA levels in all ranitidine and nizatidine samples it tested, including API and finished drug which included tablets and syrup. NDMA was present in all samples tested. Testing of ranitidine for injection is still ongoing.

For reference, consuming up to 0.096 micrograms or 0.32 parts per million (ppm) of NDMA per day is considered reasonably safe for human ingestion based on lifetime exposure. FDA has set the acceptable daily intake limit for NDMA at 0.096 micrograms or 0.32 ppm for ranitidine. Although many manufacturers have already recalled ranitidine voluntarily, FDA will recommend recalls to manufacturers with NDMA levels above the acceptable daily intake limit.

The methods FDA used in the laboratory testing are available here.

FDA also developed a simulated gastric fluid (SGF) model to be used with the LC-MS testing method to estimate the biological significance of in vitro findings. The SGF and simulated intestinal fluid (SIF) models are intended to detect the formation of NDMA in systems that approximate the stomach and intestinal fluids, respectively.  The results of these tests showed no additional NDMA generated in the stomach.

NDMA ESTIMATED RISK:

FDA has determined that the levels of NDMA in ranitidine and nizatidine are similar to the levels you would expect to be exposed to if you ate common foods like grilled or smoked meats.

Company

Product

Lots Tested

NDMA level ppm

NDMA level (micrograms-mcg/tablet or oral dose)

Sanofi Pharmaceutical

OTC Ranitidine 150mg

19E413M, 19D554, 19A432U, 19C540, 19D431I, 19D442N, 19D423M, 19D464M,

0.07-2.38

0.01-0.36

Sanofi Pharmaceutical

OTC Ranitidine 75mg

18L012U, 9A003U, 19B006M, 18M025M, 18N023U, 19B005N, 19A002U, 18N026U

0.10-0.55

0.01-0.04

Cardinal Health

OTC Ranitidine 150mg

9FE2953

1.02

0.15

Watson

Rx Nizatidine 150mg

1350798M

0.05

0.01

Watson

Rx Nizatidine 300mg

1333973A

0.04

0.01

Strides Shasun Ltd

Rx Nizatidine 150mg

7704758A

0.11

0.02

Strides Shasun Ltd

Rx Nizatidine 300mg

7704022A

0.09

0.03

Novitium

Rx Ranitidine 300mg

S18038B

2.85

0.86

Dr Reddy's

Rx Ranitidine 300mg

C805265

0.68

0.20

Strides Shasun Ltd

Rx Ranitidine 300mg

7702255A

0.11

0.03

Sandoz

Rx Ranitidine 300mg

HU2207

0.82

0.25

Strides Shasun Ltd

Rx Ranitidine 300mg

7704537A

0.02

0.00

Aurobindo

Rx Ranitidine 300mg

RA3019001-A

1.86

0.56

Ajanta Pharma USA Inc

Rx Ranitidine 300mg

PA1229B

0.23

0.07

Silarx Pharma

Ranitidine 150mg Syrup

3652081-02661

1.37

0.20

Pharma Associates

Ranitidine 150mg Syrup

BE00, BF75, BF77, BF78, BDFF, COAC

0.03-0.07

0.004-0.012

Amneal Pharmaceuticals Ranitidine 300mg

AR181795A, AR190878A, AR190876A, AR191177A, HB05819, HB06119, HL08718

0.52-2.17

0.16-0.65

Sanofi Pharmaceutical Ranitidine 150mg 19D570, 19D428U, 19E408M 0.08-2.17 0.01-0.33

Back to Top